Company / Net Debt per Share
BridgeBio Pharma, Inc. Net Debt per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$7.56
FY2025
5-year range
-$1.39 / $7.56
FY2021-FY2025
Trend
+643.2%
vs FY2024
Sector context
#22 of 82
Health Care
What the data says
Net Debt per Share changed +643% YoY in FY2025, a notable deviation from the 7-year average annual change of +63%.
Based on SEC 10-K filings.
7.56 in FY2025 with a 3-year CAGR of +173.8%.
Increased from $0.46 to $7.56 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +173.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#61 of 82 in Health CareTop 73% of 82This company $7.56 Sector average $1.13
▼
+569.1% above sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 643.2% year-over-year.
- Ranks #22 out of 82 companies in the Health Care sector.
- Lowest net debt per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.56 | +643.2% |
| FY2024 | -$1.39 | -400.6% |
| FY2023 | $0.46 | +25.7% |
| FY2022 | $0.37 | -39.4% |
| FY2021 | $0.61 | +128.7% |
| FY2020 | -$2.12 | +27.3% |
| FY2019 | -$2.92 | +52.8% |
| FY2018 | -$6.18 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026